🌟 [ 14 ]   How new Alzheimers drug Leqembi works, risks and who might benefit [ @CBS News ]

The FDA has approved a drug for people in the early stages of Alzheimer s disease. CBS News chief medical correspondent Dr. Jon LaPook explains how it works, the risks and who might benefit. #news #alzheimer #health Each weekday morning, CBS Mornings” co-hosts Gayle King, Tony Dokoupil and Nate Burleson bring you the latest breaking news, smart conversation and in-depth feature reporting. CBS Mornings airs weekdays at 7 a.m. on CBS and stream it at 8 a.m. ET on the CBS News app. Subscribe to “CBS Mornings” on YouTube: [ 🔗 Click ‼️ ] Watch CBS News: [ 🔗 Click ‼️ ] Download the CBS News app: [ 🔗 Click ‼️ ] Follow CBS Mornings on Instagram: [ 🔗 Click ‼️ ] Like CBS Mornings on Facebook: [ 🔗 Click ‼️ ] Follow CBS Mornings on Twitter: [ 🔗 Click ‼️ ] Subscribe to our newsletter: [ 🔗 Click ‼️ ] Try Paramount+ free: [ 🔗 Click ‼️ ] For video licensing inquiries, contact: [email protected]

:::: Visit my YouTube channel @ CBS News ( [ 🔗 Click ‼️ ] News )

🌈 🔎 HownewAlzheimersdrugLeqembiworksrisksandwhomightbenefit 🌈